Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02923531 |
| Title | Addition of X4P-001 to Nivolumab Treatment in Patients With Renal Cell Carcinoma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | X4 Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Washington | District of Columbia | United States | Details | |||
| Boston | Massachusetts | United States | Details | |||
| Hackensack | New Jersey | United States | Details | |||
| Chapel Hill | North Carolina | United States | Details |